Zenith Health Care Ltd Stock Price Today (NSE: ZENITHHE)

Zenith Health Care Ltd

3.120.05 (1.58%)
Market Closed

Fundamental Score

...

Zenith Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Zenith Health Care Ltd share price today is 3.12, down 1.58% on NSE/BSE as of 17 June 2026. Zenith Health Care Ltd (ZENITHHE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 19.72 (Cr). The 52-week high for ZENITHHE share price is 4.99 and the 52-week low is 2.23. The company has a Return on Equity (ROE) of 0.81% and a debt-to-equity ratio of 0.00.

Zenith Health Care Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
3.59
Low
2.23
Volume
30.3K
Change
+33.47%

Zenith Health Care Ltd share price chart: 33.47% return over the past month. 52-week high ₹4.99, 52-week low ₹2.23.

Zenith Health Care Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
3.303.313.223.2317.93K (Cr)
3.243.253.203.2320.04K (Cr)
3.173.173.153.1714.04K (Cr)
3.183.233.103.177.26K (Cr)
3.153.223.123.1631.11K (Cr)
3.153.343.153.1729.34K (Cr)
3.353.353.023.1527.41K (Cr)
3.233.343.153.1848.15K (Cr)
3.373.373.163.2810.51K (Cr)
3.433.433.263.2914.61K (Cr)

Zenith Health Care Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
2.403.592.403.23+34.58%
3.263.582.232.42-25.77%
3.343.853.113.30-1.20%
3.364.123.193.36+0.00%
3.703.843.053.35-9.46%
3.973.993.203.74-5.79%
4.204.353.703.94-6.19%
4.014.994.014.21+4.99%
4.094.623.334.27+4.40%
4.254.473.924.03-5.18%
4.564.564.014.40-3.51%

AI Research Briefing

Powered by Gemini · 2026-04-09

Microcap pharma play with brutal headwinds and questionable execution.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEBreakdown. 1M: 5.25%, 3M: -13.48%, 6M: -22.89%.Expensive, P/E of 37.76x vs industry P/E of 31.77x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. Stock is down 3.31% on April 7, 2026, closing at Zenith Health Care announced stable Q3 results (ending February 2025) but its evaluation score decreased, signaling potential shifts in financial health and market position.

CORE STORY (THE REAL GAME)

Zenith Health Care is a micro-cap play on contract manufacturing and exports of generic formulations to developing markets. The real game is whether they can scale operations and improve profitability in a highly competitive landscape.

Why Now
  • Generic export growth potential
  • Contract manufacturing diversification
  • Low base effect offers potential for turnaround
Potential Catalysts
  • Significant new export contracts
  • Successful backward integration into APIs
  • Improved quarterly earnings
Key Risks
  • Microcap liquidity risk
  • Negative sales and profit CAGR
  • Low ROE and high P/E
Institutional Activity

Promoter holding stable at 28.74%. No significant FII/DII activity.

Macro Context

Indian pharma exports are growing, but pricing pressures and trade uncertainties remain.

Cash Flow Quality

No. Free Cash Flow 5Y: ₹0.38 Cr.

3–6 Month Outlook

3-6 month thesis hinges on securing new contracts and demonstrating improved profitability. Failure to do so will likely lead to further downside.

Primary Thesis Risk

Inability to scale operations and improve profitability will lead to value erosion.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

0.81%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

3.12%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

1.56%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Zenith Health Care Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

28.74%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.39%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

55.56%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-25.08%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-1.11%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-36.25%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-36.25%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

0.38 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Zenith Health Care Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ZENITHHE across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (55.56%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.81%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.12%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (1.56%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Revenue Contraction (-25.08%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-1.11% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-36.25% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-36.25% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Low Promoter Commitment (28.74%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

Limited Institutional Interest (FII+DII: 0.39%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Zenith Health Care Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Zenith Health Care Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
9.5/100
3
₹19.72
0.81%
Poor
3.12%
Poor
0.0
Excellent
-36.25%
Poor
-1.11%
Poor
0.00%
65.2/100
1844
₹433738.68
37.6
Average
16.86%
Good
20.21%
Excellent
0.1
Excellent
23.78%
Excellent
9.87%
Good
0.89%
67.9/100
6798
₹170445.88
68.6
Average
15.35%
Good
20.44%
Excellent
0.0
Excellent
10.41%
Good
11.65%
Good
0.47%
65.3/100
4538
₹126430.62
58.4
Average
26.52%
Excellent
27.05%
Excellent
0.3
Excellent
13.84%
Good
7.72%
Good
0.86%
Cipla Ltd...
CIPLA500087
59/100
1418
₹123059.76
22.6
Average
17.77%
Good
22.72%
Excellent
0.0
Excellent
28.68%
Excellent
9.97%
Good
0.85%
59.2/100
1319
₹105224.96
18.2
Average
17.96%
Good
22.69%
Excellent
0.2
Excellent
22.28%
Excellent
13.26%
Good
0.63%
Lupin Ltd...
LUPIN500257
66.7/100
2276
₹95148.15
22.0
Average
20.62%
Excellent
21.30%
Excellent
0.3
Excellent
54.88%
Excellent
8.11%
Good
0.58%
68.7/100
957
₹94253.78
18.7
Average
21.21%
Excellent
24.31%
Excellent
0.4
Excellent
25.92%
Excellent
10.27%
Good
1.17%
50.6/100
2420
₹92012.53
52.6
Average
14.68%
Average
15.98%
Good
0.6
Good
11.73%
Good
15.79%
Excellent
0.04%
28.8/100
1436
₹70798.69
20.7
Average
11.08%
Average
14.18%
Average
0.2
Excellent
3.87%
Average
6.55%
Good
0.33%
59.5/100
5452
₹67075.29
28.5
Average
19.39%
Good
20.38%
Excellent
0.2
Excellent
13.93%
Good
9.21%
Good
0.80%

Zenith Health Care Ltd PE Ratio History

Historical price-to-earnings ratio for ZENITHHE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.04₹5.17136.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Zenith Health Care Ltd Quarterly Performance

Latest quarterly metrics for ZENITHHE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-25.08%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

55.56%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-1.11%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-36.25%

Compounded annual net profit growth over 5 years

Zenith Health Care Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ZENITHHE — calculated from daily price history

39RSI 14
Neutral — RSI 39

Momentum is balanced — neither overbought nor oversold.

SMA 50
3
▼ Price below SMA 50 — Short-term bearish
SMA 200
4
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
31K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Zenith Health Care Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Zenith Health Care Ltd (ZENITHHE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Zenith Health Care Ltd

About ZENITHHE (Zenith Health Care Ltd)

Zenith Health Care Ltd is a dynamic pharmaceutical entity operating within the vibrant Indian healthcare landscape. Focusing on both production and distribution, Zenith specializes... in crafting a diverse portfolio of pharmaceutical formulations. Their product range encompasses a variety of delivery methods including conventional tablets and capsules, easily administered oral liquids designed for palatability and ease of use, and sterile injectables meeting stringent safety protocols. Zenith's operational model extends beyond its own branded product lines, incorporating contract manufacturing services where they leverage their manufacturing expertise for other pharmaceutical companies, contributing to the broader pharmaceutical supply chain. They are known for their adherence to international quality standards and cost-effective production. Zenith Health Care has strategically established a robust international presence, exporting its pharmaceutical products to a wide array of global markets. Their distribution network extends across multiple continents, reaching countries spanning Southeast Asia, Africa, and Latin America. Within Southeast Asia, Zenith supplies essential medicines to nations like Cambodia and Myanmar, while also contributing to healthcare provision in Papa New Guinea and Sri Lanka. Their African market presence is substantial, with a significant supply chain reaching countries such as Kenya, Nigeria, Gambia, Zambia, Namibia, and Botswana. Further demonstrating its global reach, Zenith has established distribution channels in Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey. Zenith Health Care operates with a commitment to quality and affordability, striving to make essential medicines accessible to a global population. By offering a diverse range of dosage forms and engaging in contract manufacturing, Zenith strategically positions itself as a versatile player in the pharmaceutical sector. Their focus on international markets and expansion into diverse regions underscores a mission to address global health challenges and meet the growing demand for reliable and affordable healthcare solutions. With a growing reputation for regulatory compliance and efficacy, Zenith Health Care continues to expand its manufacturing capabilities and strategic distribution networks, ensuring a sustainable future in the pharmaceutical landscape.

Company Details

Symbol:ZENITHHE
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Mahendra Chatrabhuj Raycha
Chairman & MD
Mr. Akshit Mahendra Raycha
Joint MD & Executive Director
Mr. Prashant Radheshyam Gupta
Chief Financial Officer

ZENITHHE Share Price: Frequently Asked Questions

What is the current share price of Zenith Health Care Ltd?

Zenith Health Care Ltd (ZENITHHE) trades at ₹3.12 on NSE and BSE. Market cap ₹19.72 (Cr). Educational data only.

What is the P/E ratio of Zenith Health Care Ltd?

Zenith Health Care Ltd has a P/E of N/Ax vs industry average 31.77x.

What is the Bull Run score for Zenith Health Care Ltd?

Zenith Health Care Ltd has a Bull Run score of 9.5/100 based on 25+ financial parameters.

Does Zenith Health Care Ltd pay dividends?

Zenith Health Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Zenith Health Care Ltd?

Zenith Health Care Ltd has ROE of 0.81%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Zenith Health Care Ltd?

Zenith Health Care Ltd has debt-to-equity of 0.00.

Is Zenith Health Care Ltd a good investment?

Bull Run gives Zenith Health Care Ltd a score of 9.5/100. This is not investment advice — consult a SEBI-registered advisor.